A team of researchers led by Professor Ningling Kang, PhD, at The Hormel Institute, University of Minnesota, has published an ...

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

Boston Scientific has signed a deal to acquire the maker of a chemotherapy infusion pump aimed at treating certain inoperable ...

编者按：2024年10月21-27日，江城武汉迎来一场学术氛围热烈、国际交流深入的会议——国际肝胆胰协会中国分会第九届学术研讨会。《肿瘤瞭望》联合《国际肝病》采访了国际肝胆胰协会（IHPBA）现任主席、法国巴黎AP-HP Paul ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed ...

Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide ...

The following is a summary of “Postoperative Exercise Training in Patients with Colorectal Liver Metastases: A Randomized ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device maker Intera Oncology for an undisclosed amount, with the ...

Boston Scientific Corp. (BSX) announced Monday it has entered into a definitive agreement to acquire Intera Oncology Inc., a ...